Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.41 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.39 |
| ▸ | CHRNG | P07510 | 1/20 | 0.39 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.39 |
| ▸ | CHRND | Q07001 | 1/20 | 0.39 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19541911 | 1.00 | TLR2 (0.56) | TLR2KMT2ACPB1CPB2CHRNB2 | |
| SCHEMBL22514287 | 0.94 | TLR2 (0.54) | TLR2KMT2ACPB1CPB2SIRT2 | |
| SCHEMBL19542141 | 0.90 | TLR2 (0.62) | TLR2KMT2ASIRT2SIRT1SIRT3 | |
| SCHEMBL30895594 | 0.89 | TLR2 (0.50) | TLR2KMT2ACPB1CPB2 | |
| SCHEMBL26447022 | 0.88 | TLR2 (0.53) | TLR2KMT2ACPB1CPB2 | |
| SCHEMBL16329533 | 0.88 | TLR2 (0.53) | TLR2KMT2ACPB1CPB2 | |
| SCHEMBL16329552 | 0.86 | TLR2 (0.54) | TLR2KMT2ACPB1CPB2 | |
| SCHEMBL19542037 | 0.86 | TLR2 (0.49) | TLR2KMT2ACPB1CPB2 | |
| SCHEMBL23447232 | 0.85 | KMT2A (0.45) | TLR2KMT2ATPSAB1 | |
| SCHEMBL30771427 | 0.85 | TLR2 (0.63) | TLR2KMT2ASIRT2SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170313656-A1 | Branched Discrete PEG Constructs | QUANTA BIODESIGN, LTD. | 2017-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170313656-A1 | Branched Discrete PEG Constructs | BTD, IDUA, DNPEP | TLR2 983/4885KMT2A 3152/4885CPB1 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.